ReP USP - Resultado da busca

Artigo de periodico
Hierarchical virtual screening based on rocaglamide derivatives to discover new potential anti-skin cancer agents (2022)
Santos, Igor V. F. dos; Borges, Rosivaldo S.; Silva, Guilherme Martins da ; Lima, Lúcio R. de; Bastos, Ruan S.; Ramos, Ryan S.; Silva, Luciane B.; Silva, Carlos Henrique Tomich de Paula da ; Santos, Cleydson Breno Rodrigues dos
Source: Frontiers in Molecular Biosciences. Unidades: FCFRP, FFCLRP
Subjects: PRODUTOS NATURAIS, NEOPLASIAS, PELE, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Igor V. F. dos et al. Hierarchical virtual screening based on rocaglamide derivatives to discover new potential anti-skin cancer agents. Frontiers in Molecular Biosciences, v. 9, p. 1-22, 2022Tradução . . Disponível em: https://doi.org/10.3389/fmolb.2022.836572. Acesso em: 18 nov. 2024.
APA
Santos, I. V. F. dos, Borges, R. S., Silva, G. M. da, Lima, L. R. de, Bastos, R. S., Ramos, R. S., et al. (2022). Hierarchical virtual screening based on rocaglamide derivatives to discover new potential anti-skin cancer agents. Frontiers in Molecular Biosciences, 9, 1-22. doi:10.3389/fmolb.2022.836572
NLM
Santos IVF dos, Borges RS, Silva GM da, Lima LR de, Bastos RS, Ramos RS, Silva LB, Silva CHT de P da, Santos CBR dos. Hierarchical virtual screening based on rocaglamide derivatives to discover new potential anti-skin cancer agents [Internet]. Frontiers in Molecular Biosciences. 2022 ; 9 1-22.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3389/fmolb.2022.836572
Vancouver
Santos IVF dos, Borges RS, Silva GM da, Lima LR de, Bastos RS, Ramos RS, Silva LB, Silva CHT de P da, Santos CBR dos. Hierarchical virtual screening based on rocaglamide derivatives to discover new potential anti-skin cancer agents [Internet]. Frontiers in Molecular Biosciences. 2022 ; 9 1-22.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3389/fmolb.2022.836572
Artigo de periodico-carta/editorial
Design, synthesis, and preclinical testing of innovative anti-cancer compounds With a high level of selectivity of action and low toxicity [Editorial] (2022)
Ferreira, Ana Maria da Costa ; Stock, Regine Schneider; Aiello, Francesca
Source: Frontiers in Molecular Biosciences. Unidade: IQ
Subjects: ANTINEOPLÁSICOS, METABOLÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Ana Maria da Costa e STOCK, Regine Schneider e AIELLO, Francesca. Design, synthesis, and preclinical testing of innovative anti-cancer compounds With a high level of selectivity of action and low toxicity [Editorial]. Frontiers in Molecular Biosciences. Lausanne: Instituto de Química, Universidade de São Paulo. Disponível em: https://doi.org/10.3389/fmolb.2022.859821. Acesso em: 18 nov. 2024. , 2022
APA
Ferreira, A. M. da C., Stock, R. S., & Aiello, F. (2022). Design, synthesis, and preclinical testing of innovative anti-cancer compounds With a high level of selectivity of action and low toxicity [Editorial]. Frontiers in Molecular Biosciences. Lausanne: Instituto de Química, Universidade de São Paulo. doi:10.3389/fmolb.2022.859821
NLM
Ferreira AM da C, Stock RS, Aiello F. Design, synthesis, and preclinical testing of innovative anti-cancer compounds With a high level of selectivity of action and low toxicity [Editorial] [Internet]. Frontiers in Molecular Biosciences. 2022 ; 9 1-2 art. 859821.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3389/fmolb.2022.859821
Vancouver
Ferreira AM da C, Stock RS, Aiello F. Design, synthesis, and preclinical testing of innovative anti-cancer compounds With a high level of selectivity of action and low toxicity [Editorial] [Internet]. Frontiers in Molecular Biosciences. 2022 ; 9 1-2 art. 859821.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3389/fmolb.2022.859821
Artigo de periodico
Anticancer compounds based on isatin-derivatives: strategies to ameliorate selectivity and efficiency (2021)
Paiva, Raphael Enoque Ferraz de; Vieira, Eduardo Guimarães ; Silva, Daniel Rodrigues da ; Wegermann, Camila Anchau ; Ferreira, Ana Maria da Costa
Source: Frontiers in Molecular Biosciences. Unidade: IQ
Subjects: ANTINEOPLÁSICOS, ALCALOIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAIVA, Raphael Enoque Ferraz de et al. Anticancer compounds based on isatin-derivatives: strategies to ameliorate selectivity and efficiency. Frontiers in Molecular Biosciences, v. 7, p. 1-24 art. 627272, 2021Tradução . . Disponível em: https://doi.org/10.3389/fmolb.2020.627272. Acesso em: 18 nov. 2024.
APA
Paiva, R. E. F. de, Vieira, E. G., Silva, D. R. da, Wegermann, C. A., & Ferreira, A. M. da C. (2021). Anticancer compounds based on isatin-derivatives: strategies to ameliorate selectivity and efficiency. Frontiers in Molecular Biosciences, 7, 1-24 art. 627272. doi:10.3389/fmolb.2020.627272
NLM
Paiva REF de, Vieira EG, Silva DR da, Wegermann CA, Ferreira AM da C. Anticancer compounds based on isatin-derivatives: strategies to ameliorate selectivity and efficiency [Internet]. Frontiers in Molecular Biosciences. 2021 ; 7 1-24 art. 627272.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3389/fmolb.2020.627272
Vancouver
Paiva REF de, Vieira EG, Silva DR da, Wegermann CA, Ferreira AM da C. Anticancer compounds based on isatin-derivatives: strategies to ameliorate selectivity and efficiency [Internet]. Frontiers in Molecular Biosciences. 2021 ; 7 1-24 art. 627272.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3389/fmolb.2020.627272

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects